Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: Xetra
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

MRK:GR

119.150 EUR 0.190 0.16%

As of 14:25:10 ET on 05/17/2013.

Company Profile for Merck KGaA (MRK)

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Contact Information

Merck KGaA

Frankfurter Strasse 250
Darmstadt, 64293
Germany
Phone: 49-6151-72-0
Fax: 49-6151-72-5577

Key Executives for Merck KGaA (MRK)

Karl-Ludwig KleyChairman-Mgmt Board/CEOMatthias ZachertCFO/Member-Mgmt Board
Kai BeckmannChief Administration OfficerBernd ReckmannMember-Mgmt Board
Stefan OschmannMember-Mgmt Board

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil